Asosiy kontentga oʻtish
AkademIndex

Xizmatlar

← Ishga qaytish

Ushbu ish iqtibos qilgan ishlar

154 ta ish

Ish: A perspective on emerging therapies in metastatic colorectal cancer: Focusing on molecular medicine and drug resistance

  1. Human Epidermal Growth Factor Receptor 2 (HER2) in Cancers: Overexpression and Therapeutic Implications

    Nida Iqbal, Nida Iqbal, Naveed Iqbal +1

    Sharh maqolaOchiq kirish20146 iqtibos
    ABI

  2. Comprehensive review of targeted therapy for colorectal cancer

    Yuanhong Xie, Yingxuan Chen, Jing‐Yuan Fang

    Sharh maqolaOchiq kirish20205 iqtibos
    ABI

  3. Diagnosis and Treatment of Metastatic Colorectal Cancer

    Leah H. Biller, Deborah Schrag

    Sharh maqola20215 iqtibos
    ABI

  4. AKT/PKB Signaling: Navigating the Network

    Brendan D. Manning, Alex Toker

    Sharh maqola20174 iqtibos
    ABI

  5. Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities

    Tanzida Zubair, Debasish Bandyopadhyay

    Sharh maqola20234 iqtibos
    ABI

  6. The Role of mTOR Signaling as a Therapeutic Target in Cancer

    N. V. Popova, Manfred Jücker

    Sharh maqolaOchiq kirish20213 iqtibos
    ABI

  7. Emerging Role of ERBB2 in Targeted Therapy for Metastatic Colorectal Cancer: Signaling Pathways to Therapeutic Strategies

    Nannan Wang, Yuepeng Cao, Chengshuai Si +5

    Sharh maqola20223 iqtibos
    ABI

  8. Immune Checkpoint Inhibitors in Cancer Therapy

    Yavar Shiravand, Faezeh Khodadadi, Seyyed Mohammad Amin Kashani +6

    Sharh maqola20223 iqtibos
    ABI

  9. Characteristics of the cancer stem cell niche and therapeutic strategies

    Feng Ju, Manar Atyah, Nellie Horstmann +6

    Sharh maqola20223 iqtibos
    ABI

  10. Autophagy, cancer stem cells and drug resistance

    Alexandra G. Smith, Kay F. Macleod

    Sharh maqolaOchiq kirish20182 iqtibos
    ABI

  11. VEGF/VEGFR-Targeted Therapy and Immunotherapy in Non-small Cell Lung Cancer: Targeting the Tumor Microenvironment

    Yueshui Zhao, Sipeng Guo, Jian Min Deng +13

    Sharh maqolaOchiq kirish20222 iqtibos
    ABI

  12. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer

    Jennifer L. Hsu, Mien‐Chie Hung

    Sharh maqolaOchiq kirish20162 iqtibos
    ABI

  13. The ErbB/HER family of protein-tyrosine kinases and cancer

    Robert Roskoski

    Sharh maqola20132 iqtibos
    ABI

  14. New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: do all roads lead to RAS?

    Giuseppe Bronte, Nicola Silvestris, Marta Castiglia +10

    Sharh maqolaOchiq kirish20152 iqtibos
    ABI

  15. Vascular Endothelial Growth Factor as an Anti-Angiogenic Target for Cancer Therapy

    Gang Niu, Xiaoyuan Chen

    Sharh maqola20102 iqtibos
    ABI

  16. Microsatellite Instability in Colorectal Cancer

    C. Richard Boland, Ajay Goel

    Sharh maqola20102 iqtibos
    ABI

  17. Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years

    Mariusz Pańczyk

    Sharh maqola20142 iqtibos
    ABI

  18. The emerging clinical relevance of genomics in cancer medicine

    Michael F. Berger, Elaine R. Mardis

    Sharh maqola20182 iqtibos
    ABI

  19. NTRK fusion-positive cancers and TRK inhibitor therapy

    Emiliano Cocco, Maurizio Scaltriti, Alexander Drilon

    Sharh maqola20182 iqtibos
    ABI

  20. Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?

    Olivier Gires, Min Pan, Henrik Schinke +2

    Sharh maqola20202 iqtibos
    ABI

  21. Growth Factors, PI3K/AKT/mTOR and MAPK Signaling Pathways in Colorectal Cancer Pathogenesis: Where Are We Now?

    Constantin Ștefani, Daniela Miricescu, Iulia-Ioana Stănescu-Spînu +4

    Sharh maqola20212 iqtibos
    ABI

  22. Impact of<scp>DNA</scp>damage response defects in cancer cells on response to immunotherapy and radiotherapy

    Daniel Czajkowski, Radosław Szmyd, Harriet E. Gee

    Sharh maqola20222 iqtibos
    ABI

  23. HER2 in Colorectal Cancer: The Long and Winding Road From Negative Predictive Factor to Positive Actionable Target

    Selma Ahcene Djaballah, Francesca Daniel, A. Milani +2

    Maqola20222 iqtibos
    ABI

  24. DNA Damage Response in Cancer Therapy and Resistance: Challenges and Opportunities

    Dana Jurkovičová, Christiana M. Neophytou, Ana Čipak Gašparović +1

    Sharh maqola20222 iqtibos
    ABI

  25. Resistance to targeted therapy in metastatic colorectal cancer: Current status and new developments

    Yuanling Tang, Dandan Li, Jiayu Duan +2

    Sharh maqola20232 iqtibos
    ABI